GENE ONLINE|News &
Opinion
Blog

2026-06-01|

SAIC’s First Quarter Fiscal Year 2027 Results Show Revenue of $1.9 Billion

by GOAI
Share To

SAIC announced its first quarter fiscal year 2027 results, revealing key financial figures and strategic moves. The company reported revenue of $1.9 billion, an increase of 3% compared to the same period last year. Additionally, SAIC’s diluted earnings per share reached $1.95, marking a 7% rise year-over-year.

The revenue increase was attributed to growth in the company’s defense and civilian sectors. SAIC’s operating income totaled $140 million, representing a 7.4% operating margin. The company also highlighted its successful completion of several key contract milestones and its continued focus on strategic investments in technology and talent. Looking ahead, SAIC reaffirmed its full-year guidance, projecting revenue between $7.5 billion and $7.7 billion and diluted earnings per share between $7.50 and $7.70.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 1, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Insilico Medicine’s ISM8969 Enters Phase 1 Trial, Advancing Brain-Penetrant NLRP3 Inhibitor for Neuroinflammation and CNS Disorders
2026-06-18
PNC Multifamily Capital Launches $251.4 Million Affordable Housing Investment Fund
2026-06-18
ArcelorMittal, thyssenkrupp, and voestalpine Call for EU Emissions Trading System Reforms to Protect Steel Competitiveness
2026-06-18
Hillman Group and Hillwood Begin Construction on Dallas-Fort Worth Multipurpose Facility
2026-06-18
Six Taipei Biotechs Head to BIO 2026 in San Diego, With Precision Medicine, Drug Delivery, and Bioprocess Innovation in Focus
2026-06-18
2026 Tang Prize in Biopharmaceutical Science Honors Three Pioneers of “Living Drug” Immunotherapies
2026-06-17
How One South Korean Hospital Built a Global Reputation Around a $5 Billion Surgical Standard
2026-06-16
Scroll to Top